10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,697,733 | -26.0% | 89,642 | +0.2% | 0.01% | -18.2% |
| Q2 2023 | $4,997,791 | -3.9% | 89,502 | -4.0% | 0.01% | -8.3% |
| Q1 2023 | $5,200,967 | +53.1% | 93,224 | 0.0% | 0.01% | +50.0% |
| Q4 2022 | $3,397,082 | +21.8% | 93,224 | -4.8% | 0.01% | +14.3% |
| Q3 2022 | $2,790,000 | -37.0% | 97,954 | 0.0% | 0.01% | -36.4% |
| Q2 2022 | $4,432,000 | -39.5% | 97,954 | +1.8% | 0.01% | -21.4% |
| Q1 2022 | $7,320,000 | -46.9% | 96,225 | +4.0% | 0.01% | -44.0% |
| Q4 2021 | $13,784,000 | +7.7% | 92,537 | +5.3% | 0.02% | 0.0% |
| Q3 2021 | $12,797,000 | -25.0% | 87,903 | +0.9% | 0.02% | -21.9% |
| Q2 2021 | $17,056,000 | +28.6% | 87,099 | +18.9% | 0.03% | +23.1% |
| Q1 2021 | $13,259,000 | +25.7% | 73,255 | -1.7% | 0.03% | +23.8% |
| Q4 2020 | $10,551,000 | +35.9% | 74,511 | +19.7% | 0.02% | +16.7% |
| Q3 2020 | $7,762,000 | +48.6% | 62,256 | +6.5% | 0.02% | +38.5% |
| Q2 2020 | $5,222,000 | – | 58,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |